Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of ACVBP Plus Rituximab in Previously Untreated Patients Aged From 18 to 59 Years With High Risk Diffuse Large B-cell Lymphoma (Age-adjusted IPI = 2-3)

NCT00144807 is registered in ClinicalTrials.gov with Lymphoma Study Association as lead sponsor.

NCT NCT00144807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00144807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of ACVBP Plus Rituximab in Previously Untreated Patients Aged From 18 to 59 Years With High Risk Diffuse Large B-cell Lymphoma (Age-adjusted IPI = 2-3)
Lead sponsor
Lymphoma Study Association
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2003
Completion date
April 30, 2012
Enrollment
128 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large cell lymphoma